Comparison of the solution conformations of a cell-adhesive peptide LBE and its reverse sequence EBL.
Comparison of the solution conformations of a cell-adhesive peptide LBE and its reverse sequence EBL.
复制标题
细胞粘附肽 LBE 及其反向序列 EBL 的溶液构象比较。
DOI:
10.1080/07391102.1999.10508375
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Siahaan,TJ
中科院分区:
文献类型:
--
作者:
Jois,SD;Hughes,R;Siahaan,TJ
T-cell adhesion is mediated by an ICAM-l/LFA-1 interaction; this interaction plays a crucial role in T-cell activation during immune response. LBE peptide, which is derived from the β-subunit of LFA-1, has been shown to inhibit ICAM-l/LFA-l-mediated T-cell adhesion. In this work, we studied the solution conformations of LBE peptide and its reverse sequence (EBL) by NMR, CD and molecular dynamics simulations. Reverse peptides have been used as controls in biological studies. The effect of reversing the sequence of LBE to EBL peptides on their respective conformations is important in understanding their biological propertiesin vitroorin vivo.The NMR studies for these peptides were carried out in water and in TFE/water solvent systems. In 40% TFE/water, both peptides exhibited helical conformation. CD studies suggested that the LBE exhibits 30% helical conformation, while the EBL exhibits 20% helical conformation. From the NMR and MD simulation studies, it was evident that the peptides exhibited a stable helical conformation; a stable helical structure was found at Leu6 to Leu 15 for LBE and at Gly9 to Leu 17 for EBL. The helical conformations of LBE and EBL may be in equilibrium with other possible conformers; the other conformers contain loop and turn structures. Both peptides bind to divalent cations because the LBE is derived from the cation-binding region of the LFA-1. This study shows that reversing the peptide sequence did not alter the secondary structure of the corresponding sequence. Hence, caution must be exercised when using reverse peptides as controls in biological studies. This report will improve our ability to design a better inhibitor of ICAM-l/LFA-1 interaction.